| |
IRD patientsa |
Non-IRD patients |
Healthy Controls |
| n |
11 |
14 |
36 |
| Age
(years)
|
44 (34-56)
|
41 (33-64)
|
36 (23-71)b
|
| CD4+ T-cells/μl blood
[Nadir, Week 0]
|
22 (0-58)
|
27 (0-104)
|
NA
|
| CD4+ T-cells/μl blood)
[Week 16 (11-37)]
|
142 (78-307)
|
176 (54-338)
|
NA
|
| %CD4+ T-cells of lymphocytes
[Week 0]
|
2.0 (0.5-9.4)
|
3.9 (0.2-10.8)
|
35.2 (20.0-46.4)c
|
| %CD4+ T-cells of lymphocytes
[Week 24 (13-32)]
|
10.2 (4.1-15.7)
|
8.6 (2.8-20.5)
|
35.2 (20.0-46.4)c
|
Values are presented as median (range), NA = not available
aAll parameters assessed were similar to non-IRD patients
bLower than all HIV patients (p < 0.05)
cHigher than all HIV patients (p < 0.05) |
